Fortress Biotech, Inc.
FBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001429260
No open-market purchases or sales by Fortress Biotech, Inc. insiders were filed in the last 90 days; 55 institutions reported holding it in 13F filings for Q2 2026, worth $17.7M in total; no superinvestor holds it.
Other share classesFBIOP
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Fortress Biotech, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Fortress Biotech, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Jin David | Chief Financial Officer | 1,651,571 | Jun 24, 2026 | 3 |
| Rosenwald Lindsay A MD | PRESIDENT, CEO & CHAIRMAN | 4,586,841 | Mar 20, 2026 | 1 |
| Weiss Michael S | Executive Vice Chairman | 2,276,562 | Mar 20, 2026 | 1 |
| Lobell J Jay | Director | 192,397 | Jan 5, 2026 | 1 |
| Hoenlein Malcolm | Director | 115,747 | Jan 5, 2026 | 1 |
| Harvey Jimmie | Director | 146,704 | Jan 5, 2026 | 1 |
| Klein Dov | Director | 130,105 | Jan 5, 2026 | 1 |
| Lorenz Kevin | Director | 101,009 | Jan 5, 2026 | 1 |
| Lu Lucy | Director | 61,273 | Jan 3, 2025 | 0 |
| Rowinsky Eric K | Director | 68,797 | Jan 3, 2024 | 0 |
| Hunter Robyn | Chief Financial Officer | 163,877 | Apr 29, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 25, 2024 (view filing)4:45 PM ET | Sep 23 | 2 days | Rosenwald Lindsay A MDPRESIDENT, CEO & CHAIRMAN | PPurchaseCommon stock, par value $0.001 | +763.4K | $1.84 | +$1.40M | +26.4%3.66M after | |
| Sep 25, 2024 (view filing)4:45 PM ET | Sep 23 | 2 days | Rosenwald Lindsay A MDPRESIDENT, CEO & CHAIRMAN | PPurchase | +763.4K | $0.125 | +$95.4K | –763.4K after | Derivative |
| Jul 15, 2024 (view filing) | Jul 11 | 4 days | Rosenwald Lindsay A MDPresident, CEO & Chairman | PPurchaseSERIES A CUMULATIVE PERPETUAL PREFERRED STOCK | +5.00K | $7.48 | +$37.4K | +4.1%127.5K after | |
| Jul 12, 2024 (view filing) | Jul 10 | 2 days | Jin DavidChief Financial Officer | PPurchaseSERIES A CUMULATIVE PERPETUAL PREFERRED STOCK | +500 | $7.50 | +$3.75K | New position500 after | |
| Jul 11, 2024 (view filing) | Jul 9 | 2 days | Rosenwald Lindsay A MDPresident, CEO & Chairman | PPurchaseSERIES A CUMULATIVE PERPETUAL PREFERRED STOCK | +5.00K | $7.39 | +$37.0K | +4.3%122.5K after | |
| Jul 10, 2024 (view filing) | Jul 8 | 2 days | Rosenwald Lindsay A MDPresident, CEO & Chairman | PPurchaseSERIES A CUMULATIVE PERPETUAL PREFERRED STOCK | +5.00K | $7.35 | +$36.8K | +4.4%117.5K after | |
| Jul 1, 2024 (view filing) | Jun 28 | 3 days | Rosenwald Lindsay A MDPresident, CEO & Chairman | PPurchaseCOMMON STOCK, PAR VALUE $0.001 | +20.0K | $1.64 | +$32.8K | +0.7%2.89M after | |
| May 20, 2024 (view filing) | May 16 | 4 days | Rosenwald Lindsay A MDPresident, CEO & Chairman | PPurchaseCOMMON STOCK, PAR VALUE $0.001 | +10.0K | $1.76 | +$17.6K | +0.3%2.87M after | |
| May 20, 2024 (view filing) | May 20 | Same day | Klein DovDirector | SSaleCOMMON STOCK, PAR VALUE $0.001 | −10.0K | $1.89 | −$18.9K | −15.8%53.4K after | |
| Jan 9, 2024 (view filing) | Jan 5 | 4 days | Rosenwald Lindsay A MDPresident, CEO & Chairman | PPurchaseCOMMON STOCK, PAR VALUE $0.001 | +50.0K | $2.38 | +$119.0K | +1.8%2.86M after | |
| Nov 16, 2023 (view filing) | Nov 14 | 2 days | Rosenwald Lindsay A MDPresident, CEO & Chairman | PPurchaseCOMMON STOCK, PAR VALUE $0.001 | +1.57M | $1.70 | +$2.66M | +152.2%2.60M after | |
| Nov 16, 2023 (view filing) | Nov 14 | 2 days | Rosenwald Lindsay A MDPresident, CEO & Chairman | PPurchase | +1.57M | $0.00 | $0 | –1.57M after | Derivative |
| Nov 16, 2023 (view filing) | Nov 14 | 2 days | Weiss Michael SSee Remarks | PPurchaseCOMMON STOCK, PAR VALUE $0.001 | +147.1K | $1.70 | +$250.0K | +15.0%1.13M after | |
| Nov 16, 2023 (view filing) | Nov 14 | 2 days | Weiss Michael SSee Remarks | PPurchase | +147.1K | $0.00 | $0 | –147.1K after | Derivative |
| Sep 27, 2023 (view filing)8:20 AM ET | Sep 26 | 1 day | Rosenwald Lindsay A MDPresident, CEO & Chairman | PPurchaseCOMMON STOCK, PAR VALUE $0.001 | +100.0K | $0.2833 | +$28.3K | +0.7%15.4M after | |
| Aug 21, 2023 (view filing) | Aug 17-18 | 4 days | Rosenwald Lindsay A MDPresident, CEO & Chairman | PPurchaseSERIES A CUMULATIVE PERPETUAL PREFERRED STOCK | +20.0K | $10.55 | +$210.9K | +21.6%112.5K after | 2 lots |
| Feb 14, 2023 (view filing) | Feb 10 | 4 days | Weiss Michael SSee Remarks | PPurchaseCOMMON STOCK, PAR VALUE $0.001 | +1.20M | $0.84 | +$1.01M | +8.8%14.8M after | |
| Feb 14, 2023 (view filing) | Feb 10 | 4 days | Rowinsky Eric KDirector | PPurchaseCOMMON STOCK, PAR VALUE $0.001 | +12.0K | $0.84 | +$10.1K | +1.3%932.0K after | |
| Feb 14, 2023 (view filing) | Feb 10 | 4 days | Rosenwald Lindsay A MDPresident, CEO & Chairman | PPurchaseCOMMON STOCK, PAR VALUE $0.001 | +2.40M | $0.84 | +$2.01M | +18.5%15.3M after | |
| Feb 14, 2023 (view filing) | Feb 10 | 4 days | Lu LucyDirector | PPurchaseCOMMON STOCK, PAR VALUE $0.001 | +12.0K | $0.84 | +$10.1K | +9.9%133.4K after | |
| Feb 14, 2023 (view filing) | Feb 10 | 4 days | Lobell J JayDirector | PPurchaseCOMMON STOCK, PAR VALUE $0.001 | +299.4K | $0.84 | +$251.5K | +22.4%1.64M after | |
| Feb 14, 2023 (view filing) | Feb 10 | 4 days | Jin DavidChief Financial Officer | PPurchaseCOMMON STOCK, PAR VALUE $0.001 | +35.9K | $0.84 | +$30.2K | +2.6%1.44M after | |
| Dec 5, 2022 (view filing) | Dec 1 | 4 days | Rosenwald Lindsay A MDPRESIDENT, CEO & CHAIRMAN | PPurchaseCOMMON STOCK, PAR VALUE $0.001 | +100.0K | $0.68 | +$68.0K | +0.9%11.7M after | |
| Dec 2, 2022 (view filing) | Nov 30 | 2 days | Rosenwald Lindsay A MDPRESIDENT, CEO & CHAIRMAN | PPurchaseCOMMON STOCK, PAR VALUE $0.001 | +5.00K | $0.56 | +$2.80K | 0.0%11.6M after | |
| Dec 2, 2022 (view filing) | Nov 30 | 2 days | Jin DavidChief Financial Officer | PPurchaseCOMMON STOCK, PAR VALUE $0.001 | +5.00K | $0.56 | +$2.80K | +0.4%1.40M after | |
| Oct 24, 2022 (view filing) | Oct 21 | 3 days | Rosenwald Lindsay A MDPRESIDENT, CEO & CHAIRMAN | PPurchaseCOMMON STOCK, PAR VALUE $0.001 | +100.0K | $0.70 | +$70.0K | +0.9%11.6M after | |
| Apr 29, 2022 (view filing) | Dec 28, 2021 | 122 daysLate | Klein DovDirector | SSaleCommon Stock, par value $0.001 | −5.00K | $2.45 | −$12.3K | −0.8%651.0K after | |
| Apr 29, 2022 (view filing) | Sep 21, 2021 | 220 daysLate | Hunter RobynChief Financial Officer | SSaleCommon Stock, par value $0.001 | −28.3K | $3.13 | −$88.6K | −14.7%163.9K after |